Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

OnabotulinumtoxinA wear-off in chronic migraine, observational cohort study.

Zidan A, Roe C, Burke D, Mejico L.

J Clin Neurosci. 2019 Jul 18. pii: S0967-5868(19)30877-X. doi: 10.1016/j.jocn.2019.07.043. [Epub ahead of print]

PMID:
31327585
2.

Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients.

Ali SS, Bragin I, Rende E, Mejico L, Werner KE.

Cureus. 2019 Mar 29;11(3):e4343. doi: 10.7759/cureus.4343.

3.

Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial.

Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, Wall M; and the NORDIC IIHTT Study Group.

Headache. 2017 Sep;57(8):1195-1205. doi: 10.1111/head.13153. Epub 2017 Jul 28.

4.

Re: Oculomotor nerve tumors masquerading as recurrent painful ophthalmoplegic neuropathy.

Shin RK, Mejico LJ, Boghen D.

Cephalalgia. 2016 Jul;36(8):814. doi: 10.1177/0333102415607071. Epub 2015 Sep 21. No abstract available.

PMID:
26391456
5.

CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.

Kattah JC, Pula JH, Mejico LJ, McDermott MP, Kupersmith MJ, Wall M.

J Neurol. 2015 Oct;262(10):2271-4. doi: 10.1007/s00415-015-7838-9. Epub 2015 Jul 10.

PMID:
26159101
6.

IgG4-related ophthalmic disease.

Mejico LJ.

Saudi J Ophthalmol. 2015 Jan-Mar;29(1):53-6. doi: 10.1016/j.sjopt.2014.09.008. Epub 2014 Sep 27. Review.

7.

Transient ocular motor nerve palsies associated with presumed cranial nerve schwannomas.

Shin RK, Mejico LJ, Kawasaki A, Purvin VA, Moster ML, Younge BR, Boghen D.

J Neuroophthalmol. 2015 Jun;35(2):139-43. doi: 10.1097/WNO.0000000000000220.

PMID:
25742198
8.

Impairment of habituation of the auditory brain stem response in migrainous vertigo.

Brodsky JR, Mejico LJ, Giraud A, Woods CI 3rd.

Ann Otol Rhinol Laryngol. 2013 May;122(5):308-15.

PMID:
23815047
9.

Progressive diplopia and facial weakness in a 62-year-old woman.

Kolloori MR, Mejico LJ, Corbo J, Sharma A, Ko MW.

J Neuroophthalmol. 2012 Dec;32(4):359-62. doi: 10.1097/WNO.0b013e31825daccd. No abstract available.

PMID:
23196947
10.

IgG4-related inflammatory pseudotumor of the central nervous system responsive to mycophenolate mofetil.

Moss HE, Mejico LJ, de la Roza G, Coyne TM, Galetta SL, Liu GT.

J Neurol Sci. 2012 Jul 15;318(1-2):31-5. doi: 10.1016/j.jns.2012.04.010. Epub 2012 Apr 28.

11.

Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients.

Christophi GP, Christophi JA, Gruber RC, Mihai C, Mejico LJ, Massa PT, Jubelt B.

J Neurol Sci. 2011 Aug 15;307(1-2):41-5. doi: 10.1016/j.jns.2011.05.024. Epub 2011 Jun 11.

12.

Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study.

Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, Mejico LJ, Volpe NJ, Galetta SL, Balcer LJ, Liu GT.

Neurology. 2011 May 3;76(18):1564-7. doi: 10.1212/WNL.0b013e3182190f51.

PMID:
21536635
13.

Nonvestibulocochlear cranial nerve schwannomas.

Mejico LJ.

Curr Treat Options Neurol. 2010 Jan;12(1):37-42. doi: 10.1007/s11940-009-0053-1.

PMID:
20842488
14.

Retinal vascular occlusion syndromes.

Haymore JG, Mejico LJ.

Int Ophthalmol Clin. 2009 Summer;49(3):63-79. doi: 10.1097/IIO.0b013e3181a8db88. Review. No abstract available.

PMID:
19584622
15.

Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.

Christophi GP, Panos M, Hudson CA, Tsikkou C, Mihai C, Mejico LJ, Jubelt B, Massa PT.

Clin Immunol. 2009 Oct;133(1):27-44. doi: 10.1016/j.clim.2009.05.019. Epub 2009 Jun 25.

16.

Stereotactic radiosurgery in two cases of presumed fourth cranial nerve schwannoma.

Petrela E, Hodge CJ, Hahn SS, Chung CT, Mejico LJ.

J Neuroophthalmol. 2009 Mar;29(1):54-7. doi: 10.1097/WNO.0b013e31818f6463.

PMID:
19458578
17.

Late onset optic neuropathy in methylmalonic and propionic acidemia.

Williams ZR, Hurley PE, Altiparmak UE, Feldon SE, Arnold GL, Eggenberger E, Mejico LJ.

Am J Ophthalmol. 2009 May;147(5):929-33. doi: 10.1016/j.ajo.2008.12.024. Epub 2009 Feb 25.

PMID:
19243738
18.

SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.

Christophi GP, Hudson CA, Gruber RC, Christophi CP, Mihai C, Mejico LJ, Jubelt B, Massa PT.

Lab Invest. 2008 Mar;88(3):243-55. doi: 10.1038/labinvest.3700720. Epub 2008 Jan 21.

20.

Multiple bilateral extraocular muscle metastases as the initial manifestation of breast cancer.

Spitzer SG, Bersani TA, Mejico LJ.

J Neuroophthalmol. 2005 Mar;25(1):37-9.

PMID:
15756132
21.

A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.

Vitale S, Miller NR, Mejico LJ, Perry JD, Medura M, Freitag SK, Girkin C.

Am J Ophthalmol. 2004 Jul;138(1):18-32.

PMID:
15234278
22.

Infliximab-associated retrobulbar optic neuritis.

Mejico LJ.

Arch Ophthalmol. 2004 May;122(5):793-4. No abstract available.

PMID:
15136342
23.
24.

Therapies with potential toxicity of neuro-ophthalmic interest.

Iuorno JD, Kolostyak KP, Mejico LJ.

Curr Opin Ophthalmol. 2003 Dec;14(6):339-43. Review.

PMID:
14615637
25.

14th International Neuro-Ophthalmology Society (INOS) Meeting, Buenos Aires, Argentina, May 5-8, 2002.

McFadzean RM, Mejico LJ.

J Neuroophthalmol. 2002 Dec;22(4):305-10. No abstract available.

PMID:
12464735
26.
27.

New therapies with potential neuro-ophthalmologic toxicity.

Mejico LJ, Bergloeff J, Miller NR.

Curr Opin Ophthalmol. 2000 Dec;11(6):389-94. Review.

PMID:
11141631
28.

Pathologic findings in a steroid-responsive optic nerve infarct in giant-cell arteritis.

Kattah JC, Mejico L, Chrousos GA, Zimmerman LE, Manz HJ.

Neurology. 1999 Jul 13;53(1):177-80.

PMID:
10408556

Supplemental Content

Loading ...
Support Center